The third Fragment-Based Drug Discovery Down Under Meeting (FBDD-DU3) will be held from the 12th-15th of November 2019 at the Monash Institute of Pharmaceutical Sciences, in Melbourne.
The 2019 conference will bring together an expanding multidisciplinary group of biologists, biochemists, biophysicists, and chemists from academia and industry to hear about the latest techniques and progress in the dynamic and exciting field of fragment-based drug design.
Registration and abstract submission now open!
Abstract submission for orals and posters EXTENDED to 11th October 2019
Authors notified 18th October 2019
Registration deadline 31st October 2019
- Martin Scanlon (Chair)
- Indu Chandrashekaran
- Menachem Gunzburg
- Christopher MacRaild
- Olga Ilyichova
- Biswaranjan Mohanty
- Bradley Doak
- Narelle Tunstall
Please contact email@example.com if you have any questions